Trial intelligence / Profile preview

Morphine added to local lidocaine for pain prevention after mastoidectomy-tympanoplasty

IRCT20171230038142N3Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
May 2016
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, single-blind trial of morphine, lidocaine and epinephrine in postoperative pain (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Severity of postoperative pain, Hemodynamic changes during mastoidectomy-tympanoplasty and 1 more. Started May 2016; status: completed.

02

Drugs

morphinelidocaineepinephrine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20171230038142N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171230038142N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call